文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

抗生素对肠道携带者中多重耐药菌根除的影响——一项荟萃分析的系统评价

The Effect of Antibiotics on the Eradication of Multidrug-Resistant Organisms in Intestinal Carriers-A Systematic Review with Meta-Analysis.

作者信息

Knudsen Maja Johanne Søndergaard, Rubin Ingrid Maria Cecilia, Petersen Andreas Munk

机构信息

Department of Clinical Microbiology, Copenhagen University Hospital-Amager and Hvidovre, 2650 Hvidovre, Denmark.

Gastrounit, Medical Section, Copenhagen University Hospital-Amager and Hvidovre, 2650 Hvidovre, Denmark.

出版信息

Antibiotics (Basel). 2024 Aug 9;13(8):747. doi: 10.3390/antibiotics13080747.


DOI:10.3390/antibiotics13080747
PMID:39200047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11350669/
Abstract

OBJECTIVES: The aim of this systematic review was to investigate the effect of antibiotics on the eradication of multidrug-resistant organisms (MRO) in intestinal carriers. We defined multidrug-resistant organisms as vancomycin-resistant (VREfm), and multidrug-resistant Gram-negative Methods: We searched the EMBASE, Cochrane Central, and PubMed databases from inception to medio November 2023. We included randomised and controlled clinical trials (RCTs), that investigated the effect of antibiotics on the eradication of multidrug-resistant organisms in intestinal carriers. Finally, we performed a meta-analysis. RESULTS: We included five RTCs in the systematic review. In four studies an effect of antibiotics on the eradication of MRO was shown at the end of intervention, but it was not sustained at follow-up. In the fifth study, the effect at the end of intervention was not reported, and there was no observed effect of the intervention at follow-up. We included four studies in the meta-analysis, and it suggests an effect of antibiotics on the eradication of MRO in intestinal carriers at the end of follow-up with a -value of 0.04 (95% confidence interval 1.02-1.95). None of the studies reported a significant increase in resistance to the study drug. Gastrointestinal disorders were the most frequent non-severe adverse event. CONCLUSIONS: The effect of antibiotics on the eradication of multidrug-resistant organisms in intestinal carriers was not statistically significant in any of the five included studies; however, we found a significant effect in the pooled meta-analysis. As the confidence interval is large, we cannot determine the clinical importance of this finding, and it should be further investigated.

摘要

目的:本系统评价旨在研究抗生素对肠道携带者中多重耐药菌(MRO)根除的影响。我们将多重耐药菌定义为耐万古霉素肠球菌(VREfm)和多重耐药革兰阴性菌。方法:我们检索了EMBASE、Cochrane中心和PubMed数据库,检索时间从数据库建立至2023年11月中旬。我们纳入了调查抗生素对肠道携带者中多重耐药菌根除影响的随机对照临床试验(RCT)。最后,我们进行了荟萃分析。 结果:我们在系统评价中纳入了5项RTC。在4项研究中,干预结束时显示抗生素对多重耐药菌的根除有效果,但在随访时未持续。在第5项研究中,未报告干预结束时的效果,随访时也未观察到干预效果。我们在荟萃分析中纳入了4项研究,结果表明随访结束时抗生素对肠道携带者中多重耐药菌的根除有效果,P值为0.04(95%置信区间1.02 - 1.95)。没有研究报告对研究药物的耐药性显著增加。胃肠道疾病是最常见的非严重不良事件。 结论:在纳入的5项研究中,没有一项研究显示抗生素对肠道携带者中多重耐药菌的根除效果具有统计学意义;然而,我们在汇总的荟萃分析中发现了显著效果。由于置信区间较大,我们无法确定这一发现的临床重要性,应进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a1/11350669/de930535a9af/antibiotics-13-00747-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a1/11350669/d42bd70847bf/antibiotics-13-00747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a1/11350669/de930535a9af/antibiotics-13-00747-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a1/11350669/d42bd70847bf/antibiotics-13-00747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a1/11350669/de930535a9af/antibiotics-13-00747-g002.jpg

相似文献

[1]
The Effect of Antibiotics on the Eradication of Multidrug-Resistant Organisms in Intestinal Carriers-A Systematic Review with Meta-Analysis.

Antibiotics (Basel). 2024-8-9

[2]
GG Versus Placebo for Eradication of Vancomycin-Resistant in Intestinal Carriers: A Systematic Review and Meta-Analysis.

Microorganisms. 2023-11-19

[3]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[4]
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.

Cochrane Database Syst Rev. 2022-12-13

[5]
No Effect of Lactobacillus rhamnosus GG on Eradication of Colonization by Vancomycin-Resistant Enterococcus faecium or Microbiome Diversity in Hospitalized Adult Patients.

Microbiol Spectr. 2022-6-29

[6]
Prevalence of and risk factors for intestinal colonisation by multidrug-resistant Gram-negative bacteria in patients with haematological malignancies: A systematic review and meta-analysis.

Int J Antimicrob Agents. 2024-1

[7]
Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis.

Lancet Infect Dis. 2023-6

[8]
Interventions to improve antibiotic prescribing practices for hospital inpatients.

Cochrane Database Syst Rev. 2013-4-30

[9]
Evaluation of the Association Between Gastric Acid Suppression and Risk of Intestinal Colonization With Multidrug-Resistant Microorganisms: A Systematic Review and Meta-analysis.

JAMA Intern Med. 2020-4-1

[10]
Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.

Cochrane Database Syst Rev. 2021-10-7

本文引用的文献

[1]
Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature.

J Infect Public Health. 2023-3

[2]
Long-term ecological and evolutionary dynamics in the gut microbiomes of carbapenemase-producing Enterobacteriaceae colonized subjects.

Nat Microbiol. 2022-10

[3]
No Effect of Lactobacillus rhamnosus GG on Eradication of Colonization by Vancomycin-Resistant Enterococcus faecium or Microbiome Diversity in Hospitalized Adult Patients.

Microbiol Spectr. 2022-6-29

[4]
The use of core genome multilocus sequence typing to determine the duration of vancomycin-resistant Enterococcus faecium outbreaks.

APMIS. 2022-6

[5]
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.

Lancet. 2022-2-12

[6]
Substantial Decrease in Vancomycin-Resistant Outbreak Duration and Number of Patients During the Danish COVID-19 Lockdown: A Prospective Observational Study.

Microb Drug Resist. 2022-1

[7]
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

BMJ. 2021-3-29

[8]
Oral decontamination with colistin plus neomycin in solid organ transplant recipients colonized by multidrug-resistant Enterobacterales: a multicentre, randomized, controlled, open-label, parallel-group clinical trial.

Clin Microbiol Infect. 2021-6

[9]
Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms.

Clin Infect Dis. 2021-4-26

[10]
Oral Capsulized Fecal Microbiota Transplantation for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization With a Metagenomic Perspective.

Clin Infect Dis. 2021-7-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索